UDG Healthcare Public Limited Co. CFO appointment (7107Z)
December 19 2017 - 2:00AM
UK Regulatory
TIDMUDG
RNS Number : 7107Z
UDG Healthcare Public Limited Co.
19 December 2017
UDG HEALTHCARE PLC
("UDG Healthcare" or the "Company")
CFO Appointment
19 December 2017: UDG Healthcare, a leading international
healthcare services provider, is pleased to announce the
appointment of Nigel Clerkin as Chief Financial Officer of the
Company. Nigel will start with the Company on 1 May 2018 and will
replace Alan Ralph from that date. Alan will support the transition
until his previously announced retirement in November 2018.
Nigel most recently held the position of Chief Financial Officer
with ConvaTec Group plc, a London Stock Exchange listed company,
where he worked for the last three years. ConvaTec is a global
medical products and technologies company, employing approximately
9,000 employees worldwide. Prior to this, Nigel held roles in Elan
Corporation plc, most recently as Executive Vice President and
Chief Financial Officer, culminating in its sale to Perrigo Company
plc in 2013. He started his career as an auditor with KPMG and is a
qualified Chartered Accountant.
As Chief Financial Officer, the finance and the investor
relations functions of UDG Healthcare will report into Nigel. Nigel
will also be appointed a Director of the Company in May 2018.
Brendan McAtamney, UDG Healthcare's Chief Executive Officer,
commented:
"We are delighted to welcome Nigel to UDG Healthcare. Nigel
brings with him significant industry experience and an excellent
track record of leading finance functions in the international
healthcare sector. As we focus on our strategy, capitalising on the
increasing trend within healthcare to outsource non-core and
specialist activities, Nigel's appointment reinforces our
commitment to attracting talent with relevant sectoral and
operational experience that will help us implement that strategy.
Together with the board and the wider executive team, I am very
much looking forward to working with Nigel."
Nigel Clerkin commented:
"I am very happy to be joining UDG Healthcare at such an
exciting time. Over the past number of years, UDG Healthcare has
been transforming and growing into market leader positions within
its key geographies. I look forward to building on this strong
platform and helping Brendan and the team drive further
international expansion across the Group."
There is no further information in relation to Nigel Clerkin's
current or prior directorships that requires notification for the
purpose of Listing Rule 9.6.13.
For further information,
please contact:
UDG Healthcare
Keith Byrne
Head of IR, Strategy & Corporate
Communications
Tel: + 353-1-468-9000
Powerscourt
Lisa Kavanagh / Jack Hickey
Tel: + 44-207-250-1446
About UDG Healthcare plc
UDG Healthcare plc (LON: UDG) is a leading international partner
of choice delivering advisory, commercial, clinical, communications
and packaging services to the healthcare industry, employing over
9,000 people with operations in 24 countries and delivering
services in over 50 countries.
UDG Healthcare plc operates across three divisions: Ashfield,
Sharp and Aquilant.
Ashfield is a global leader in commercialisation services for
the pharmaceutical and healthcare industry, operating across three
broad areas of activity: advisory, communications and commercial
& clinical services. It focuses on supporting healthcare
professionals and patients at all stages of the product life cycle.
The division provides field and contact centre sales teams,
healthcare communications, patient support, audit, advisory,
medical information and event management services to over 300
healthcare companies.
Sharp is a global leader in contract commercial packaging and
clinical trial packaging services for the pharmaceutical and
biotechnology industries, operating from state-of-the-art
facilities in the US and Europe.
Aquilant is a leading provider of outsourced sales, marketing,
distribution and engineering services to the medical and scientific
sectors in the UK, Ireland and the Netherlands.
The company is listed on the London Stock Exchange and is a
constituent of the FTSE 250.
For more information, please go to: www.udghealthcare.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAFFLFWAFWSEIE
(END) Dow Jones Newswires
December 19, 2017 02:00 ET (07:00 GMT)
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2023 to Apr 2024